Aung T, Celestin M, Bau S, Saab S
Cureus. 2025; 16(12):e76018.
PMID: 39835005
PMC: 11743697.
DOI: 10.7759/cureus.76018.
Akiyama M, Alshehri W, Saito K, Takeuchi T, Kaneko Y
Drugs Aging. 2025; 42(2):111-126.
PMID: 39755996
DOI: 10.1007/s40266-024-01172-3.
Xu J, Zhai J, Zhao J
Front Immunol. 2024; 15:1413860.
PMID: 38911857
PMC: 11190345.
DOI: 10.3389/fimmu.2024.1413860.
Muller R, Ebbo M, Habert P, Daniel L, Briantais A, Chanez P
Respirology. 2022; 28(2):120-131.
PMID: 36437514
PMC: 10100266.
DOI: 10.1111/resp.14422.
Matza M, Perugino C, Harvey L, Fernandes A, Wallace Z, Liu H
Lancet Rheumatol. 2022; 4(2):e105-e112.
PMID: 35425928
PMC: 9004478.
DOI: 10.1016/S2665-9913(21)00359-3.
Multi-organ IgG4-related disease continues to mislead clinicians: A case report and literature review.
Strainiene S, Sarlauskas L, Savlan I, Liakina V, Stundiene I, Valantinas J
World J Clin Cases. 2020; 8(15):3267-3279.
PMID: 32874981
PMC: 7441269.
DOI: 10.12998/wjcc.v8.i15.3267.
IgG4-related disease: a contemporary review.
Karadeniz H, Vaglio A
Turk J Med Sci. 2020; 50(SI-2):1616-1631.
PMID: 32777900
PMC: 7672352.
DOI: 10.3906/sag-2006-375.
IgG4-Related Disease: Beyond Glucocorticoids.
Akiyama M, Takeuchi T
Drugs Aging. 2018; 35(4):275-287.
PMID: 29546609
DOI: 10.1007/s40266-018-0534-6.
The Immunologic Paradoxes of IgG4-Related Disease.
Xiao X, Lian M, Zhang W, Gershwin M, Ma X
Clin Rev Allergy Immunol. 2018; 54(2):344-351.
PMID: 29460058
DOI: 10.1007/s12016-018-8679-y.
Immunoglobulin G4-related kidney diseases: An updated review.
Salvadori M, Tsalouchos A
World J Nephrol. 2018; 7(1):29-40.
PMID: 29359118
PMC: 5760510.
DOI: 10.5527/wjn.v7.i1.29.
Frequency and distribution of CD4+CXCR5+ follicular B helper T cells within involved tissues in IgG4‑related ophthalmic disease.
Yang H, Wei R, Liu Q, Shi Y, Li J
Mol Med Rep. 2017; 16(6):9512-9520.
PMID: 29039547
PMC: 5780010.
DOI: 10.3892/mmr.2017.7780.
Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients.
Ebbo M, Grados A, Samson M, Groh M, Loundou A, Rigolet A
PLoS One. 2017; 12(9):e0183844.
PMID: 28915275
PMC: 5600376.
DOI: 10.1371/journal.pone.0183844.
Diagnostic and treatment workup for IgG4-related disease.
Abraham M, Khosroshahi A
Expert Rev Clin Immunol. 2017; 13(9):867-875.
PMID: 28701054
PMC: 5896560.
DOI: 10.1080/1744666X.2017.1354698.
Emerging Treatment Models in Rheumatology: IgG4-Related Disease: Insights Into Human Immunology and Targeted Therapies.
Perugino C, Mattoo H, Mahajan V, Maehara T, Wallace Z, Pillai S
Arthritis Rheumatol. 2017; 69(9):1722-1732.
PMID: 28575535
PMC: 5575969.
DOI: 10.1002/art.40168.
Recent advances in understanding and managing IgG4-related disease.
Wolfson A, Hamilos D
F1000Res. 2017; 6.
PMID: 28299186
PMC: 5325071.
DOI: 10.12688/f1000research.9399.1.
Ophthalmic manifestations in IgG4-related disease: Clinical presentation and response to treatment in a French case-series.
Ebbo M, Patient M, Grados A, Groh M, Desblaches J, Hachulla E
Medicine (Baltimore). 2017; 96(10):e6205.
PMID: 28272212
PMC: 5348160.
DOI: 10.1097/MD.0000000000006205.
